2015-04-04T11:09:10-05:00 2014-05-31 450250958 EIDE BAILLY LLP 401 N 31ST ST STE 1120 PO BX 7112 BILLINGS MT 591037112 990 2013-06-01 810503295 MONTANA CANCER CONSORTIUM MONT 4062375460 90 POLY DRIVE NO 2 BILLINGS MT 59101 BENJAMIN MARCHELLO MD PRESIDENT 4062375460 2015-04-01 1 KIM HUNWARDSEN P00484560 6122536500 2015-03-31 2013 2016-02-25 16:41:14Z BENJAMIN MARCHELLO MD 90 POLY DRIVE NO 2 BILLINGS MT 59101 491035 0 X WWW.MTCANCER.ORG X 1995 MT PROMOTE AND SUPERVISE CANCER RESEARCH. 8 7 6 7 0 0 478719 491035 0 0 0 0 0 0 478719 491035 0 0 0 0 271333 326447 0 0 0 198223 265378 469556 591825 9163 -100790 629319 527521 0 0 629319 527521 THE MONTANA CANCER CONSORTIUM IS A NONPROFIT ORGANIZATION WHOSE MISSION IS TO BRING "STATE OF THE ART" CANCER TREATMENT TO MONTANA AND NORTHERN WYOMING THROUGH CLINICAL TRIALS SPONSORED BY THE NATIONAL CANCER INSTITUTE. 0 0 520546 MONTANA CANCER CONSORTIUM PARTICIPATES IN CLINICAL STUDIES OF CANCER PATIENTS, PROVIDES SELECTED CANDIDATES WITH EXPERIMENTAL DRUGS AND KEEPS EXTENSIVE DATA ON THE RESULTS OF TREATMENT. IN THE YEAR ENDING MAY 31, 2014, MONTANA CANCER CONSORTIUM PARTICIPATED IN APPROXIMATELY 100 CLINICAL TRIALS, 82 PATIENTS WERE REGISTERED TO TREATMENT CLINICAL TRIALS AND 47 PATIENTS WERE REGISTERED TO CANCER CONTROL CLINICAL TRIALS. THE MONTANA CANCER CONSORTIUM MEMBERSHIP CONSISTS OF 49 PHYSICIAN MEMBERS LOCATED ACROSS 10 AFFILIATE SITES IN MONTANA, NORTHERN WYOMING AND NORTHERN IDAHO. 520546 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 6 1 0 0 0 0 0 0 0 0 0 0 X 8 7 1 0 0 0 1 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 X AMANDA DINSDALE 4062375460 90 POLY DRIVE NO 2 BILLINGS MT 59101 DR BENJAMIN MARCHELLO PRESIDENT 4.00 0.50 X X 0 0 0 DR GRANT HARPER VICE-PRESIDENT 1.00 X X 0 0 0 AMANDA DINSDALE SECRETARY/TREASURER, ADMINISTRATOR 40.00 1.00 X X 68900 0 22866 DR DAVID MEYERS DIRECTOR 2.00 0.50 X 0 0 0 DR CHRISTOPHER GOULET DIRECTOR 1.00 X 0 0 0 DR JAMES HUEFTLE DIRECTOR 1.00 X 0 0 0 DR JOHN SCHALLENKAMP DIRECTOR 1.00 X 0 0 0 DR MELISSA HULVET DIRECTOR 1.00 X 0 0 0 68900 0 22866 0 0 0 0 ST VINCENT HOSPITAL 1233 N 30TH BILLINGS MT 59101 LABOR PAYMENTS 326458 BILLINGS CLINIC 2800 10TH AVENUE NORTH BILLINGS MT 59101 PATIENT PAYMENTS 107031 2 418943 72092 491035 491035 0 0 0 X 93228 46614 46614 215154 215154 18065 16019 2046 11508 11508 109450 109450 2582 2582 21648 21230 418 8111 8111 9663 9663 61045 61045 3970 3970 320 320 1917 1917 SUPPLEMENTAL FUNDING 35140 35140 24 24 591825 520546 71279 0 622796 523923 9668 6070 6523 3598 629319 527521 0 0 X 629319 527521 629319 527521 629319 527521 -100790 -1008 0 X 0 0 0 X 912539 707550 509146 478719 491035 3098989 912539 707550 509146 478719 491035 3098989 74345 3024644 3098989 3398 0.97600 0.86280 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6368 3962 2406 3300 2108 1192 3598 FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE SHALL CONSIST OF NOT FEWER THAN 3 NOR MORE THAN 5 ONCOLOGICAL PROFESSIONAL MEMBERS OF THE BOARD OF DIRECTORS AND SHALL ALWAYS INCLUDE THE PRESIDENT OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 2 DR. MARCHELLO AND DR. HUEFTLE HAVE A BUSINESS RELATIONSHIP. DR. SCHALLENKAMP AND DR. GOULET HAVE A BUSINESS RELATIONSHIP. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERS CONSIST OF ALL PARTICIPATING PRINCIPALS IN THE MONTANA CANCER CONSORTIUM CCOP EFFORT. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER SHALL BE ENTITLED TO ONE VOTE FOR EACH DIRECTOR TO BE ELECTED. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION HAS AN EXECUTIVE COMMITTEE BUT THE COMMITTEE DID NOT MEET DURING FISCAL YEAR 2014. FORM 990, PART VI, SECTION B, LINE 11 THE ORGANIZATION E-MAILS A COPY OF THE DRAFT RETURN TO THE BOARD MEMBERS FOR REVIEW PRIOR TO THE FILING OF THE FINAL FORM 990. FORM 990, PART VI, SECTION B, LINE 12C INVESTIGATORS, INDIVIDUALS WHO HAVE THE POTENTIAL TO ENROLL CLIENTS OR PATIENTS IN NIH CLINICAL TRIALS, ARE COVERED BY THE CONFLICT OF INTEREST POLICY. INVESTIGATORS ARE REQUIRED TO FILE AN ANNUAL FINANCIAL DISCLOSURE FORM AND UNDERGO FINANCIAL CONFLICT OF INTEREST (FCOI) TRAINING EVERY FOUR YEARS. THE PROGRAM ADMINISTRATOR REVIEWS THE COMPLETED FCOI ANNUAL DISCLOSURE FORMS AND FCOI TRAINING. THE PROGRAM ADMINISTRATOR NOTIFIES THE PRINCIPAL INVESTIGATOR OF THE REVIEW COMPLETION AND ANY POTENTIAL CONFLICTS. RESTRICTIONS ON INDIVIDUALS WITH A CONFLICT CAN INCLUDE, BUT ARE NOT LIMITED TO THE FOLLOWING: MONITORING OF SPONSORED PROGRAM BY AN INDEPENDENT REVIEWER, MODIFICATIONS TO THE RESEARCH OR PROGRAM PLAN, APPOINTMENT OF OVERSIGHT PANEL, PUBLIC DISCLOSURE OF SIGNIFICANT FINANCIAL INTERESTS, AND/OR LIMITATIONS ON THE INVESTIGATOR'S INVOLVEMENT IN MONTANA CANCER CONSORTIUM. FORM 990, PART VI, SECTION C, LINE 19 THE PUBLIC MAY REQUEST COPIES OF THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS BY CALLING, E-MAILING, MAILING OR REQUESTING IN PERSON. FORM 990, PART IX, LINE 11G CONTRACT PAYMENTS: PROGRAM SERVICE EXPENSES 109,450. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 109,450. BILLINGS INTERHOSPITAL ONCOLOGY 90 POLY DRIVE SUITE 2 BILLINGS MT 59101 810401858 PROMOTE AND SUPERVISE CANCER RESEARCH MT 501(C)(3) 4 MONTANA CANCER CONSORTIUM 1 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0